Financial Times Live (@ftlive) header
Financial Times Live (@ftlive) profile picture

The latest news and insights from Financial Times Live conferences & events.

Global
Joined February 2009
Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)Photo by Financial Times Live (@ftlive)
With the UK Budget offering firms “breathing space”, questions remain over investment and growth. Rain Newton-Smith, Christine Lagarde and József Váradi join The Global Boardroom, 8–9 December. Explore the speaker line-up: bit.ly/3MAsrTc #FTGlobalBoardroom
324
How can asset managers navigate global threats and policy shifts? Leaders from Natixis, Robeco, @FedHermesLtd and Ocorian will discuss this at #FTFOAM, moderated by Baptiste Aboulian. 24-25 November Find out more: bit.ly/4i2UhHV
344
Are Asia-Pacific banks seeing real returns on AI investment? This Thursday, join the FT and @Capco with leaders from Trust Bank, @MyMaybank and UOB to explore where AI is delivering value, barriers to adoption and the rise of agentic AI. Register: bit.ly/4iujBHb
408
Can Europe turn its AI ambitions into economic growth? On 3 December, the @FT and @Google will bring policymakers and business leaders together in Brussels and online to examine investment, regulation and competitiveness. #EUAIGrowth bit.ly/4sV0CsM
1
5
489
What’s the biggest risk investors are underestimating today? At the FT Global Wealth Management Summit, Mark Haefele, CIO at @UBS Global Wealth Management, examines exposure to interest rates, AI and commodities. Watch FT Live’s latest 60 Seconds With. #FTWealth
1
2
461
As private equity drives consolidation in wealth management, are clients or shareholders the real winners? At the FT Global Wealth Management Summit, Matt Conradi of @netwealth examines the implications of private equity ownership for clients. #FTWealth
2
453
Is private credit still worth the risk? At the FT Global Wealth Management Summit, @AliciaLevinePhD, CIO at BNY, examines potential returns and the importance of aligning fund structures with underlying assets. Watch FT Live’s 60 Seconds With. #FTWealth
429
How much autonomy should businesses give AI? Join Rohit Dhawan and Madhumita Murgia at The Global Boardroom, 8–9 December, to explore agentic AI, productivity and oversight. Discover more: globalboardroom.ft.com/home #FTGlobalBoardroom
1
2
420
How will Indonesia's export controls reshape commodity trade? Luke Mahony, President Director of DSI, Danantara Indonesia, joins the FT Commodities Asia Summit, 2-3 December 2026. Explore the agenda: bit.ly/3MJjerV #FTCommodities
270
Can India build a stronger minerals value chain? Join Bipasha Banerjea, Subhrakant Panda, @Vibhuti_D_Garg and Nitin Gupta at FT Metals & Mining India on 17 November to explore investment and refining. Final opportunity to apply for free: bit.ly/4kfQWaf #FTMining
2
436
What will the next generation of wealthy investors demand that private banks aren’t delivering today? At the FT Global Wealth Management Summit, @AnnekaTreon of @ING explores the evolving expectations of younger clients. Watch FT Live’s 60 Seconds With. #FTWealth
439
What's next for maritime finance? Hear from leaders at @StanChart, Pacific Basin Shipping, SeaKapital and the Hong Kong SAR Government at the FT's Hong Kong event on 17 November. Apply for a complimentary place: bit.ly/4jTgVE4 #FTLive
1
3
478
What is the pharmaceutical industry underestimating about obesity medicines? At the FT Global Pharma and Biotech Summit, Hong Chow of @novonordisk examines their long-term impact on healthcare and innovation. Watch FT Live’s 60 Seconds With. #FTPharma
477
With China and India expanding their pharmaceutical capabilities, how can the UK compete for the next generation of biotech investment? @ChrisMcDonaldMP, Minister of State for the UK Government, answered this question directly after his keynote interview at #FTPharma. #biotech
1
3
649
Health and economic policy are deeply interconnected, yet often treated separately. At the FT Global Pharma and Biotech Summit, Teresa Graham, CEO of @Roche Pharmaceuticals, highlighted the need for greater alignment between the two. #FTPharma
436
Is Europe’s ageing population a financial challenge or an economic opportunity? At the FT Global Pharma and Biotech Summit, Teresa Graham, CEO of @Roche Pharmaceuticals, urged a rethink of how we approach demographic change. #FTPharma
415